Supraventricular Tachycardia Market: Current Analysis and Forecast (2023-2030)

Report Description

The Supraventricular tachycardia market was valued at USD 557.84 million in 2022 & expected to grow at a strong CAGR of 9.5% during the forecast period (2023-2030). The rising cases of supraventricular tachycardia due to factors like aging populations and lifestyle-related issues are driving market growth. Adding to this, advances in cardiac monitoring and electrophysiology technologies improve diagnosis and treatment options. For instance, in May 2022, Bristol Myers Squibb developed mavacamten, a potential first-in-class cardiovascular medication for treatment of obstructive Hypertrophic Cardiomyopathy, a chronic heart condition with severe morbidity and patient impact, through the deal. Moreover, the growing awareness of cardiac health encourages early diagnosis and treatment of supraventricular tachycardia. Furthermore, an aging population is more prone to cardiac conditions, boosting demand for treatment options which will drive the growth of the supraventricular tachycardia market.

Some of the major players operating in the market include GSK plc., Sanofi, Bayer AG, AstraZeneca, Abbott, Teva Pharmaceutical Industries Ltd., Medtronic, Boston Scientific Corporation, Pfizer, Bristol-Myers Squibb Company. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst type, the atrioventricular nodal re-entrant tachycardia (AVNRT) segment dominated the market in 2022.”

Based on the type, the market is segmented into atrioventricular nodal re-entrant tachycardia (AVNRT), atrioventricular reciprocating tachycardia (AVRT), atrial fibrillation (AFib), and others. Amongst these, the atrioventricular nodal re-entrant tachycardia (AVNRT) segment dominated the market in 2022. It plays a significant role in driving awareness of SVT-related conditions among patients and healthcare providers. Increased awareness often leads to more diagnosis and treatment, thus indirectly contributing to the growth of the SVT industry.

“Amongst treatment, Medication held a significant share of the supraventricular tachycardia market in 2022.”

Based on the treatment, the market is segmented into medications, radiofrequency catheter ablation, and surgery. Among these, Medication held a significant share of the supraventricular tachycardia market in 2022. The growth of this segment is driven by the continuous refinement of drug therapies, making them more targeted and with fewer side effects, thus improving patient outcomes and expanding the market. Moreover, Antiarrhythmic drugs, such as beta-blockers and calcium channel blockers, are commonly prescribed to control heart rate and rhythm.

Supraventricular Tachycardia Market Report Coverage

“Asia-Pacific has extensive growth”

Asia-Pacific is expected to grow with a significant CAGR during the forecast period. This growth is driven by factors such as the growing awareness of heart health, increasing access to healthcare services, and an aging population. As of 2020, the population of Asia exceeded 4.5 billion (including China and India, the two countries with over 1 billion each), more than one-half the world’s total. There were an estimated 414 million Asian people age 65 and older, about 20% higher than the total U.S. population (331.4 million). As lifestyles become more sedentary and stressful, SVT cases rise. This, in turn, fuels the demand for diagnostic tools and treatments. The APAC SVT market offers opportunities for pharmaceutical companies, medical device manufacturers, and healthcare providers to cater to this growing demand. This cardiac arrhythmia disorder has attracted considerable attention in the region.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global supraventricular tachycardia market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Supraventricular Tachycardia Market Analysis (2023-2030)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global supraventricular tachycardia market were the three major steps undertaken to create and analyze the adoption of supraventricular tachycardia in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global supraventricular tachycardia market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the supraventricular tachycardia market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the supraventricular tachycardia market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & and sub-segments for major regions. Major segments are included in the report as a type, treatment, and distribution channels. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the supraventricular tachycardia market. Further, we conducted factor analysis using dependent and independent variables such as type, treatment, and distribution channels of the supraventricular tachycardia market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the supraventricular tachycardia market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global supraventricular tachycardia market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the supraventricular tachycardia market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global supraventricular tachycardia market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global supraventricular tachycardia market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the type, treatment, and distribution channels in the global supraventricular tachycardia market.

The main objective of the Global Supraventricular tachycardia Market Study

The current & future market trends of the global supraventricular tachycardia market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the supraventricular tachycardia market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
• Segments in the study include areas of the model, mode of delivery, component, product, application
• Define and analysis of the regulatory framework for the supraventricular tachycardia industry
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
• Analyze the current and forecast market size of the supraventricular tachycardia market for the major region
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
• Company profiles of the supraventricular tachycardia market and the growth strategies adopted by the market players to sustain in the fast-growing market
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team